Skip to main content

What the FDA labels say about taking them together

Levothyroxine and liothyronine

Liothyronine's FDA label of June 4, 2026 names levothyroxine in its drug interactions section; the levothyroxine labels PlainMeds reads (4) do not name liothyronine. The liothyronine label: “Other drugs: Amiodarone; Amiodarone inhibits peripheral conversion of levothyroxine (T4) to triiodothyronine (T3) and may cause isolated biochemical changes in clinically euthyroid patients.”

Check it at the source: the levothyroxine FDA label on DailyMed (effective February 20, 2024, AbbVie Inc.); the liothyronine FDA label on DailyMed (effective June 4, 2026, Mylan Pharmaceuticals Inc.).

What does the levothyroxine label say about liothyronine?

Levothyroxine's label (effective February 20, 2024) and its 3 other brand-application labels do not name liothyronine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Synthroid), AbbVie Inc., effective February 20, 2024 (SPL set 1e11ad30-1041-4520-10b0-8f9d30d30fcc), via openFDA; the full label on DailyMed

What does the liothyronine label say about levothyroxine?

Liothyronine label, drug interactions

Other drugs: Amiodarone; Amiodarone inhibits peripheral conversion of levothyroxine (T4) to triiodothyronine (T3) and may cause isolated biochemical changes (increase in serum free-T4, and decreased or normal free-T3) in clinically euthyroid patients.

Source: FDA drug label (Liothyronine Sodium), NDA010379 (King Pharms), as published by Mylan Pharmaceuticals Inc., effective June 4, 2026 (SPL set 115a84c2-0126-4dd7-816e-1873875f1e49), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

36Levothyroxine generic labelers
17Liothyronine generic labelers
LevothyroxineLiothyronine
Labeled forHypothyroidismHypothyroidism
Boxed warningYesYes
Pharmacy cost (NADAC)$0.0588 per tablet 112 mcg tablet$0.294 per tablet 25 mcg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?